Drug:
Reaction: PAIN
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25491700 |
US |
1 | |
Pancreatic carcinoma, Pain, |
||||
PANCRELIPASE, |
||||
| 2 | 25491719 |
US |
||
Pain, Inflammatory pain, |
||||
TALQUETAMAB, |
||||
| 3 | 25491760 |
US |
1 | |
Pain, |
||||
RISANKIZUMAB-RZAA, |
||||
| 4 | 25491765 |
CA |
40 | 2 |
Fibromyalgia, Hypertension, Ill-defined disorder, Inflammation, Injury, Irritable bowel syndrome, Liver function test increased, Malaise, Maternal exposure during pregnancy, Memory impairment, Mobility decreased, Swelling, Rash, Peripheral swelling, Pain, Osteoarthritis, Onychomycosis, Onychomadesis, Nausea, Abdominal distension, Adverse reaction, Back injury, Blood cholesterol increased, Bursitis, C-reactive protein increased, Confusional state, Depression, Dyspepsia, Dyspnoea, Facet joint syndrome, Fall, Muscle spasms, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Folliculitis, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, NICOTINAMIDE, CANDESARTAN, GOLD, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE, MINOCYCLINE, MINOCYCLINE, MINOCYCLINE, MINOCYCLINE, MIRABEGRON, MIRABEGRON, OXYCODONE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, LEFLUNOMIDE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 5 | 25491767 |
US |
49 | 2 |
Pain, Feeling abnormal, Condition aggravated, Hypokinesia, Gait inability, Speech disorder, Dyspnoea, Stress, Conversion disorder, Feeling drunk, |
||||
OFATUMUMAB, MORPHINE, PREDNISONE, |
||||
| 6 | 25491834 |
CA |
43 | 2 |
Systemic lupus erythematosus, Rash, Musculoskeletal pain, Pemphigus, Taste disorder, Urticaria, Vomiting, Pain, Stomatitis, Obesity, Peripheral swelling, Nail disorder, Night sweats, Weight increased, Wound infection, Wound, Paraesthesia, Synovitis, Nasopharyngitis, Psoriatic arthropathy, Contraindicated product administered, Rheumatoid arthritis, Swelling, Wheezing, Peripheral venous disease, Type 2 diabetes mellitus, Osteoarthritis, Product quality issue, Pericarditis, Normal newborn, |
||||
DICLOFENAC, DICLOFENAC SODIUM, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOFACITINIB, TOFACITINIB, ERENUMAB-AOOE, LISINOPRIL, PREDNISONE, PANTOPRAZOLE, QUETIAPINE FUMARATE, QUETIAPINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, RISEDRONATE SODIUM, TRAMADOL HYDROCHLORIDE, TOFACITINIB, ERENUMAB-AOOE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RANITIDINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, INFLIXIMAB, RITUXIMAB, RITUXIMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, RAMIPRIL, GOLIMUMAB, GOLIMUMAB, FISH OIL, LORAZEPAM, USTEKINUMAB, METHOTREXATE, METHOTREXATE SODIUM, SULFASALAZINE, ERENUMAB-AOOE, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 7 | 25491854 |
CN |
73 | 2 |
Hospitalisation, Disease recurrence, Dyspnoea, Chest discomfort, Abdominal distension, Pain, Discomfort, Fatigue, Drug ineffective, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 8 | 25492039 |
US |
2 | |
Muscle spasms, Discomfort, Pain, Product use in unapproved indication, Insomnia, |
||||
| 9 | 25492089 |
PL |
28 | 2 |
Skin burning sensation, Pain, Headache, Ear pain, Ear discomfort, Lip pain, Anorgasmia, Blood pressure increased, Erythema, |
||||
DIMETHYL FUMARATE, |
||||
| 10 | 25492233 |
GB |
57 | 2 |
Influenza, Malaise, Hypokinesia, Pain, Poor quality sleep, Dyspnoea, Hot flush, Weight decreased, Anaemia, Urticaria, Rash, |
||||
USTEKINUMAB, VEDOLIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
| 11 | 25492256 |
US |
2 | |
Product temperature excursion issue, Pain, Circumstance or information capable of leading to medication error, Drug effect less than expected, |
||||
| 12 | 25492271 |
CA |
43 | 2 |
Pemphigus, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Maternal exposure during pregnancy, Memory impairment, Migraine, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Osteoarthritis, Paraesthesia, Pain, No adverse event, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ERENUMAB-AOOE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LORAZEPAM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MIRABEGRON, PHENYLEPHRINE HYDROCHLORIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CANDESARTAN, CANDESARTAN, CYANOCOBALAMIN, ALENDRONATE SODIUM, GOLD, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MAGNESIUM HYDROXIDE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, ABATACEPT, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREDNISONE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RANITIDINE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 13 | 25492357 |
US |
59 | 2 |
Product dose omission issue, Pain, Rheumatoid arthritis, Product complaint, |
||||
TOCILIZUMAB, |
||||
| 14 | 25492383 |
CO |
63 | 2 |
Bile duct stenosis, Hypothyroidism, Bone pain, Abdominal pain upper, Chest pain, Eye irritation, Intervertebral disc protrusion, Ear discomfort, Pain, Irritability, Eye pain, Gait disturbance, Depressed mood, Anxiety, Treatment noncompliance, Body height decreased, Weight increased, Eye pruritus, Helicobacter infection, Dry eye, Photophobia, Inappropriate schedule of product administration, Ocular discomfort, Ocular hyperaemia, Memory impairment, Obesity, Umbilical hernia, Hiatus hernia, Hepatic steatosis, Ear pain, Malaise, Palpitations, Dizziness, Nasal congestion, Arthralgia, Headache, Fatigue, Sinusitis, Cough, Pyrexia, |
||||
VEDOLIZUMAB, |
||||
| 15 | 25492412 |
US |
2 | |
Off label use, Pain, |
||||
THYROID, PORCINE, |
||||
| 16 | 25492517 |
US |
2 | |
Influenza, Pain, Arthralgia, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, LURASIDONE HYDROCHLORIDE, |
||||
| 17 | 25492600 |
US |
||
Deafness permanent, Endocrine ophthalmopathy, Graves^ disease, Pain, Emotional distress, Anxiety, Discomfort, Tinnitus, Product use complaint, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, |
||||
| 18 | 25492613 |
US |
||
Deafness permanent, Endocrine ophthalmopathy, Graves^ disease, Pain, Emotional distress, Anxiety, Discomfort, Tinnitus, Product use complaint, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, |
||||
| 19 | 25492637 |
US |
35 | 2 |
Reproductive complication associated with device, Device breakage, Foreign body in reproductive tract, Complication of device removal, Inflammation, Unevaluable event, Pain, |
||||
COPPER, CITALOPRAM, CITALOPRAM HYDROBROMIDE, BUPROPION, |
||||
| 20 | 25492639 |
US |
2 | |
Reproductive complication associated with device, Device breakage, Foreign body in reproductive tract, Complication of device removal, Emotional distress, Pain, Discomfort, |
||||
COPPER, |
||||
| 21 | 25492644 |
US |
2 | |
Caesarean section, Device breakage, Foreign body in reproductive tract, Complication of device removal, Embedded device, Device issue, Device material issue, Procedural pain, Alopecia, Affective disorder, Uterine prolapse, Genital hypoaesthesia, Nervous system disorder, Cystocele, Uterine scar, Emotional disorder, Muscle spasms, Polymenorrhoea, Dyspareunia, Pain, Intermenstrual bleeding, |
||||
COPPER, |
||||
| 22 | 25492676 |
ES |
||
Diarrhoea, Illness, Pain, Decreased immune responsiveness, Blood cholesterol increased, Alopecia, Fatigue, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, ABEMACICLIB, ABEMACICLIB, EXEMESTANE, GOSERELIN, |
||||
| 23 | 25492847 |
US |
2 | |
Pain, |
||||
CAPSAICIN, |
||||
| 24 | 25492851 |
CO |
32 | 1 |
Parasitic gastroenteritis, Treatment noncompliance, Pain, Frequent bowel movements, Weight increased, Vomiting, Pyrexia, |
||||
VEDOLIZUMAB, |
||||
| 25 | 25492872 |
US |
50 | 2 |
Headache, Pain, Asthenia, Dizziness, Blindness transient, Loss of consciousness, |
||||
| 26 | 25493129 |
US |
2 | |
Pain, |
||||
NATALIZUMAB, |
||||
| 27 | 25493202 |
US |
||
Loss of consciousness, Gait disturbance, Pain, Joint injury, Muscular weakness, |
||||
RELUGOLIX, RELUGOLIX, AMLODIPINE BESYLATE, ATORVASTATIN CALCIUM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, DABIGATRAN ETEXILATE MESYLATE, ERGOCALCIFEROL, |
||||
| 28 | 25493258 |
US |
2 | |
Deformity, Device breakage, Foreign body in reproductive tract, Complication of device removal, Anxiety, Pain, |
||||
COPPER, |
||||
| 29 | 25493259 |
US |
42 | 2 |
Uterine cervical laceration, Reproductive complication associated with device, Device breakage, Foreign body in reproductive tract, Complication of device removal, Cervix scarring, Emotional disorder, Pain, Abdominal pain, Abnormal uterine bleeding, Procedural pain, Discomfort, Device use issue, Off label use, |
||||
COPPER, |
||||
| 30 | 25493260 |
US |
2 | |
Deformity, Device breakage, Foreign body in reproductive tract, Complication of device removal, Anxiety, Pain, |
||||
COPPER, |
||||
| 31 | 25493261 |
US |
2 | |
Deformity, Device breakage, Foreign body in reproductive tract, Complication of device removal, Anxiety, Pain, Device use issue, Off label use, |
||||
COPPER, |
||||
| 32 | 25493263 |
US |
29 | 2 |
Infertility female, Reproductive complication associated with device, Device breakage, Foreign body in reproductive tract, Complication of device removal, Embedded device, Pregnancy with contraceptive device, Drug ineffective, Depression, Anxiety, Pelvic pain, Vaginal haemorrhage, Pain, Discomfort, Infection, |
||||
COPPER, |
||||
| 33 | 25493267 |
US |
31 | 2 |
Reproductive complication associated with device, Infertility female, Device breakage, Foreign body in reproductive tract, Complication of device removal, Embedded device, Pain, Discomfort, |
||||
COPPER, ALBUTEROL SULFATE, |
||||
| 34 | 25493269 |
US |
34 | 2 |
Abortion spontaneous, Device breakage, Foreign body in reproductive tract, Complication of device removal, Embedded device, Device issue, Device material issue, Depression, Premenstrual dysphoric disorder, Pain, |
||||
COPPER, ALBUTEROL SULFATE, DULOXETINE HYDROCHLORIDE, |
||||
| 35 | 25493441 |
GB |
79 | 2 |
Hip fracture, Fall, Joint arthroplasty, Cataract, Pain, Joint injury, Blood iron decreased, Abdominal discomfort, Arterial thrombosis, Balance disorder, Pharyngeal swelling, Arthralgia, |
||||
AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, ALIROCUMAB, ALIROCUMAB, ALIROCUMAB, ALIROCUMAB, ALIROCUMAB, ALIROCUMAB, ALIROCUMAB, ALIROCUMAB, IRON, IRON, IRON, IRON, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PIROXICAM, PIROXICAM, PIROXICAM, PIROXICAM, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DALTEPARIN SODIUM, DALTEPARIN SODIUM, DALTEPARIN SODIUM, DALTEPARIN SODIUM, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, CARBOMER, CARBOMER, CARBOMER, CARBOMER, SENNOSIDES, SENNA, SENNOSIDES, SENNA, SENNOSIDES, SENNA, SENNOSIDES, SENNA, |
||||
| 36 | 25493503 |
CA |
63 | 2 |
Osteoarthritis, Arthralgia, Pain, |
||||
INSULIN GLARGINE, INSULIN DEGLUDEC, |
||||
| 37 | 25493527 |
CA |
65 | 2 |
Chills, Illness, Headache, Pain, Pyrexia, |
||||
ZOLEDRONIC ACID, |
||||
| 38 | 25493640 |
US |
68 | 2 |
Pain, Guillain-Barre syndrome, |
||||
MEPOLIZUMAB, |
||||
| 39 | 25493645 |
SE |
62 | 2 |
Myositis, Pain, Decreased appetite, Jaundice, Muscular weakness, Rhabdomyolysis, |
||||
ENALAPRIL, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 40 | 25493737 |
US |
50 | 2 |
Injection site pain, Pain, |
||||
CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, MELOXICAM, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, |
||||
| 41 | 25493765 |
CA |
43 | 2 |
Impaired healing, Joint range of motion decreased, Irritable bowel syndrome, Hypocholesterolaemia, Dry mouth, Muscle spasms, Peripheral venous disease, Hepatic enzyme increased, Glossodynia, Rash, Depression, Migraine, Wound, Exposure during pregnancy, Pain, Abdominal discomfort, Night sweats, Contraindicated product administered, Anti-cyclic citrullinated peptide antibody positive, Blister, Lung disorder, Diarrhoea, Decreased appetite, Gastrooesophageal reflux disease, Blepharospasm, Folliculitis, Paraesthesia, Blood cholesterol increased, Dizziness, Infusion related reaction, Abdominal pain upper, Headache, Peripheral swelling, Product quality issue, Memory impairment, General physical health deterioration, Arthralgia, Vomiting, Joint swelling, Taste disorder, Weight increased, Synovitis, |
||||
NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ABATACEPT, ABATACEPT, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, PHENYLEPHRINE HYDROCHLORIDE, MIRABEGRON, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, PYRIDOXINE HYDROCHLORIDE, TOFACITINIB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, QUETIAPINE FUMARATE, QUETIAPINE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, FISH OIL, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, LORAZEPAM, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, TOFACITINIB, TOFACITINIB, MEPOLIZUMAB, INFLIXIMAB, RISEDRONATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, LISINOPRIL, RAMIPRIL, CANDESARTAN, RANITIDINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TRAMADOL HYDROCHLORIDE, ERENUMAB-AOOE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, OXYCODONE, OXYCODONE, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 42 | 25493814 |
US |
60 | 2 |
Nausea, Vomiting, Hypotension, Malaise, Dehydration, Pain, |
||||
ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, |
||||
| 43 | 25493921 |
US |
66 | 1 |
Pulmonary thrombosis, Painful respiration, Back pain, Arthralgia, Pain, |
||||
RISANKIZUMAB-RZAA, |
||||
| 44 | 25493929 |
US |
||
Pain, Fatigue, Insomnia, |
||||
RELUGOLIX, RELUGOLIX, DIPHENHYDRAMINE HYDROCHLORIDE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ENZALUTAMIDE, |
||||
| 45 | 25493971 |
CA |
52 | 2 |
Gout, Crohn^s disease, Muscle spasms, Pain, |
||||
RISANKIZUMAB-RZAA, PREDNISONE, |
||||
| 46 | 25493978 |
US |
78 | 2 |
Humerus fracture, Fall, Rotator cuff syndrome, Pain, Tenderness, Peripheral swelling, Musculoskeletal stiffness, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 47 | 25494010 |
US |
26 | 2 |
Influenza like illness, Dizziness, Anxiety, Depression, Fatigue, Pain, Nausea, |
||||
SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, |
||||
| 48 | 25494044 |
US |
41 | 2 |
Dizziness, Pain, Headache, |
||||
ONABOTULINUMTOXINA, |
||||
| 49 | 25494053 |
CA |
43 | 2 |
Blepharospasm, Contraindicated product administered, Decreased appetite, Drug ineffective, Epilepsy, Gastrooesophageal reflux disease, Hypoaesthesia, Malaise, Memory impairment, Migraine, Off label use, Pain, Product quality issue, Product use in unapproved indication, Rheumatic fever, Rheumatoid factor positive, Swollen joint count increased, Taste disorder, Treatment failure, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CAFFEINE CITRATE, CALCIUM GLUCONATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, |
||||
| 50 | 25494079 |
US |
2 | |
Spinal operation, Atrial fibrillation, Burning sensation, Pain, |
||||
ABALOPARATIDE, |
||||
| 51 | 25494148 |
US |
2 | |
Loss of consciousness, Polyarthritis, Ankylosing spondylitis, Von Willebrand^s disease, Intervertebral disc displacement, Pain, Fatigue, Emotional disorder, Cervicogenic headache, Spondyloarthropathy, Abdominal pain upper, White blood cell count decreased, Essential hypertension, Migraine, Anxiety disorder, Ehlers-Danlos syndrome, Concussion, Raynaud^s phenomenon, Anaemia, Abdominal pain, Gastrooesophageal reflux disease, Rhinitis allergic, Affective disorder, Sleep apnoea syndrome, Essential tremor, Behaviour disorder, Condition aggravated, Gastritis, Neck pain, Acute sinusitis, Conjunctivitis allergic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, ADALIMUMAB, |
||||
| 52 | 25494172 |
US |
2 | |
Stress, Glycosylated haemoglobin increased, Pain, |
||||
DULAGLUTIDE, |
||||
| 53 | 25494184 |
US |
61 | 2 |
Drug ineffective for unapproved indication, Off label use, Back pain, Pain in extremity, Pain, Musculoskeletal stiffness, |
||||
TOFACITINIB, |
||||
| 54 | 25494279 |
US |
||
Urinary tract discomfort, Pain, Chills, |
||||
NADOFARAGENE FIRADENOVEC-VNCG, |
||||
| 55 | 25494323 |
US |
||
Endocrine ophthalmopathy, Graves^ disease, Deafness permanent, Pain, Emotional distress, Anxiety, Impaired quality of life, Discomfort, Tinnitus, Product use complaint, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, |
||||
| 56 | 25494429 |
CA |
65 | 2 |
Pneumonia, Dyspnoea, Pain, Oedema, Drug hypersensitivity, Malaise, Chest pain, Respiratory tract infection, Asthma, Cough, Vomiting, Wheezing, |
||||
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, AMLODIPINE BESYLATE, CALCIUM GLUCONATE, CALCIUM GLUCONATE, ROSUVASTATIN, ERGOCALCIFEROL, ERGOCALCIFEROL, HYDROMORPHONE HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, ROSUVASTATIN, ROSUVASTATIN CALCIUM, MONTELUKAST SODIUM, THEOPHYLLINE, TRAMADOL HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMINOPHYLLINE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLONAZEPAM, FLUTICASONE FUROATE, FOLIC ACID, MONTELUKAST SODIUM, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, OMALIZUMAB, OMALIZUMAB, PREDNISONE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, ROSUVASTATIN, |
||||
| 57 | 25494609 |
AU |
59 | 2 |
Multiple sclerosis relapse, Multiple sclerosis, Psoriasis, Dactylitis, Pain, Chest pain, Arthralgia, |
||||
FINGOLIMOD HCL, FINGOLIMOD, FINGOLIMOD HYDROCHLORIDE, OFATUMUMAB, |
||||
| 58 | 25494626 |
CA |
70 | 2 |
Arthralgia, Neck pain, Liver function test increased, Dyspnoea, Polymyalgia rheumatica, Rheumatoid arthritis, Pain, |
||||
METHOTREXATE SODIUM, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, METHOTREXATE SODIUM, |
||||
| 59 | 25494642 |
CA |
77 | 1 |
Dehydration, Neuropathy peripheral, Urinary incontinence, Inflammation, Dry mouth, Pain, Discomfort, Decreased activity, Cognitive disorder, Dyskinesia, Defaecation urgency, Muscle spasms, Loss of personal independence in daily activities, Taste disorder, Malaise, Hepatic enzyme increased, Blood copper increased, Abdominal rigidity, Dizziness, Fall, Reflexes abnormal, Head injury, Urine output increased, Abdominal pain, Myalgia, Muscular weakness, Gait disturbance, Vision blurred, Back pain, Constipation, Musculoskeletal pain, Lacrimation increased, Conjunctivitis, Dry eye, Infusion site extravasation, Decreased appetite, Vomiting, Nausea, Rash, Anaemia, Diarrhoea, Fatigue, Decreased appetite, Drug effect less than expected, Product use issue, |
||||
| 60 | 25494667 |
IT |
7 | 2 |
Hyperpyrexia, Psoriasis, Malaise, Pruritus, Pain, Impaired quality of life, Drug ineffective, |
||||
CYCLOSPORINE, IXEKIZUMAB, IXEKIZUMAB, PREDNISONE, |
||||
| 61 | 25494965 |
US |
77 | 1 |
Acute kidney injury, Abdominal discomfort, Abdominal mass, Anaemia, Anxiety, Prostatic specific antigen increased, Hypoacusis, Hyperlipidaemia, Haematoma, Hypertension, Muscular weakness, Glucose tolerance impaired, Rash, Weight decreased, Nausea, Pain, Headache, |
||||
VENETOCLAX, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, ACALABRUTINIB, BACLOFEN, MELATONIN, SULFACETAMIDE SODIUM, SEMAGLUTIDE, NAPROXEN, NAPROXEN SODIUM, PANTOPRAZOLE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LEVOTHYROXINE, DOXAZOSIN, DOXAZOSIN MESYLATE, ERGOCALCIFEROL, TAMSULOSIN HYDROCHLORIDE, ALLOPURINOL, OBINUTUZUMAB, ISOSORBIDE DINITRATE, HYDROCHLOROTHIAZIDE, LOSARTAN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, MAGNESIUM OXIDE, SIMVASTATIN, VENLAFAXINE HYDROCHLORIDE, |
||||
| 62 | 25495081 |
GB |
||
Syringe issue, Dizziness, Pain, Emphysema, Rheumatoid lung, |
||||
TOCILIZUMAB, |
||||
| 63 | 25495119 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain upper, Accidental overdose, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Aspiration, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Decreased appetite, Depression, Diarrhoea, Dizziness, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Hypocholesterolaemia, Impaired healing, Inflammation, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, Obesity, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Product quality issue, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Adverse event, Hospitalisation, |
||||
ABATACEPT, ABATACEPT, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LORAZEPAM, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM GLUCONATE, CANDESARTAN, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CYANOCOBALAMIN, CYANOCOBALAMIN, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ETANERCEPT, ERENUMAB-AOOE, ERENUMAB-AOOE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, SARILUMAB, LAMOTRIGINE, LAMOTRIGINE, LANSOPRAZOLE, LANSOPRAZOLE, LISINOPRIL, LISINOPRIL, LORAZEPAM, LORAZEPAM, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RANITIDINE, INFLIXIMAB, RISEDRONATE SODIUM, RITUXIMAB, RITUXIMAB, FISH OIL, FISH OIL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TRAMADOL HYDROCHLORIDE, TOFACITINIB, TOFACITINIB, |
||||
| 64 | 25495120 |
CA |
30 | 2 |
Colitis ulcerative, Pain, Feeling abnormal, Migraine, Large intestine polyp, Arthralgia, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, PREDNISONE, |
||||
| 65 | 25495123 |
FR |
37 | 2 |
Myositis, Myalgia, Swelling, Motor dysfunction, Pain, Blood creatine phosphokinase increased, |
||||
TRABECTEDIN, |
||||
| 66 | 25495169 |
CN |
56 | 2 |
Papule, Pyrexia, Pain, |
||||
CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, CARBAMAZEPINE, |
||||
| 67 | 25495190 |
IN |
74 | 2 |
Pain, Malaise, Dyspepsia, Hyperchlorhydria, Discomfort, Intentional dose omission, |
||||
CRIZOTINIB, CRIZOTINIB, |
||||
| 68 | 25495267 |
US |
2 | |
Pain, |
||||
MEPOLIZUMAB, |
||||
| 69 | 25495378 |
US |
2 | |
Vaginal haemorrhage, Pain, |
||||
LEVONORGESTREL, |
||||
| 70 | 25495392 |
US |
2 | |
Pain, Abdominal discomfort, Abdominal discomfort, |
||||
LEVONORGESTREL, |
||||
| 71 | 25495400 |
US |
2 | |
Pain, Nausea, |
||||
DIMETHYL FUMARATE, |
||||
| 72 | 25495411 |
US |
72 | 2 |
Pain, Diarrhoea, |
||||
LENALIDOMIDE, |
||||
| 73 | 25495420 |
DE |
25 | 1 |
Erectile dysfunction, Shock, Dependence, Dementia, Suicidal ideation, Poisoning, Constipation, Malaise, Vomiting, Language disorder, Disturbance in attention, Weight increased, Skin laceration, Abdominal distension, Agitation, Salivary hypersecretion, Urinary tract infection, Movement disorder, Visual impairment, Polydipsia, Staring, Exercise tolerance decreased, Feeling abnormal, Pain, Thinking abnormal, Thinking abnormal, Hypersomnia, Sluggishness, Dyspnoea, Somnolence, Hypersensitivity, Drug ineffective, |
||||
OLANZAPINE, PALIPERIDONE, |
||||
| 74 | 25495487 |
US |
||
Surgery, Pain, Contusion, |
||||
UBLITUXIMAB, |
||||
| 75 | 25495587 |
US |
19 | 2 |
Dermatitis atopic, Skin discomfort, Sleep disorder due to a general medical condition, Pain, Rash, |
||||
DUPILUMAB, |
||||
| 76 | 25495653 |
US |
68 | 2 |
Gait disturbance, Pain, Activities of daily living decreased, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 77 | 25495688 |
US |
2 | |
Pain, |
||||
DUPILUMAB, CELECOXIB, TIZANIDINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ALBUTEROL SULFATE, MONTELUKAST SODIUM, MONTELUKAST, |
||||
| 78 | 25495808 |
US |
19 | 1 |
Pain, |
||||
TEPLIZUMAB-MZWV, |
||||
| 79 | 25495921 |
US |
5 | 2 |
Rash erythematous, Pain, Urticaria, Eczema, |
||||
DUPILUMAB, |
||||
| 80 | 25496227 |
US |
2 | |
Drug abuse, Pain, Victim of sexual abuse, Victim of crime, Contusion, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, ALPRAZOLAM, |
||||
| 81 | 25496294 |
IT |
1 | 1 |
Febrile neutropenia, Pain, Asthenia, |
||||
DOXORUBICIN, |
||||
| 82 | 25496300 |
US |
70 | 1 |
Peripheral swelling, Pain, |
||||
ABATACEPT, |
||||
| 83 | 25496382 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, Chest pain, Cough, Malaise, Pain, Respiratory tract infection, Nasal oedema, |
||||
MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, OMALIZUMAB, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, MOXIFLOXACIN HYDROCHLORIDE, MONTELUKAST, RISEDRONATE SODIUM, AMLODIPINE BESYLATE, ROSUVASTATIN, ROSUVASTATIN, RITUXIMAB, RITUXIMAB, RISEDRONATE SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMINOPHYLLINE, CALCIUM, CALCIUM, CLONAZEPAM, ERGOCALCIFEROL, FLUTICASONE FUROATE, FLUTICASONE PROPIONATE, FOLIC ACID, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, PREDNISONE, ROPIVACAINE HYDROCHLORIDE, MONTELUKAST SODIUM, THEOPHYLLINE, TRAMADOL HYDROCHLORIDE, ERGOCALCIFEROL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CALCIUM CARBONATE, ANTACID, CEFADROXIL, POLYMYXIN B SULFATE, ROSUVASTATIN CALCIUM, CIPROFLOXACIN HYDROCHLORIDE, |
||||
| 84 | 25496387 |
US |
23 | 2 |
Pain, Injection site rash, Dysphagia, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 85 | 25496551 |
CA |
74 | 2 |
Pain, Back pain, Flatulence, Swelling, Liver disorder, Eating disorder, Hepatic enzyme increased, |
||||
GUSELKUMAB, GUSELKUMAB, |
||||
| 86 | 25496552 |
PR |
48 | 2 |
Syncope, Pain, Agitation, |
||||
POMALIDOMIDE, |
||||
| 87 | 25496618 |
US |
22 | 1 |
Intestinal obstruction, Pain, |
||||
RISANKIZUMAB-RZAA, |
||||
| 88 | 25496652 |
US |
62 | 2 |
Gallbladder disorder, Pain, Vomiting, Hot flush, Cold flash, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 89 | 25499799 |
68 | 2 | |
Pain, Gait disturbance, Musculoskeletal stiffness, Mobility decreased, Sitting disability, Asthenia, |
||||
CIPROFLOXACIN HYDROCHLORIDE, ADALIMUMAB-AQVH, ERGOCALCIFEROL, MAGNESIUM, |
||||
| 90 | 25504129 |
|||
Urticaria, Pain, |
||||
OXCARBAZEPINE, |
||||
| 91 | 25504285 |
48 | 2 | |
Arthralgia, Pain in extremity, Arthritis, Pain, |
||||
TIRZEPATIDE, VORTIOXETINE, BUPROPION HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, ROSUVASTATIN, LORAZEPAM, CALCIUM, |
||||
| 92 | 25491085 |
US |
58 | 2 |
Neurodermatitis, Rebound effect, Pruritus, Pain, |
||||
DUPILUMAB, |
||||
| 93 | 25491217 |
US |
2 | |
Pain, Headache, |
||||
DUPILUMAB, |
||||
| 94 | 25491276 |
US |
64 | 1 |
Pain, Weight increased, |
||||
DUPILUMAB, PREDNISONE, |
||||
| 95 | 25491377 |
CA |
55 | 2 |
Rash, Decreased activity, Dysstasia, Gait disturbance, General physical health deterioration, Grip strength decreased, Illness, Inappropriate schedule of product administration, Influenza, Pain, Psoriatic arthropathy, Treatment failure, Condition aggravated, |
||||
METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CELECOXIB, HYDROCORTISONE, DESOXIMETASONE, ADALIMUMAB, HYDROXYCHLOROQUINE, INFLIXIMAB, MELOXICAM, MELOXICAM, NAPROXEN, NAPROXEN SODIUM, HYDROXYCHLOROQUINE SULFATE, TRAMADOL HYDROCHLORIDE, PREDNISONE, INFLIXIMAB, SULFASALAZINE, ADALIMUMAB-ADAZ, |
||||
| 96 | 25491381 |
US |
68 | 1 |
Polymyalgia rheumatica, Pain, |
||||
SARILUMAB, |
||||
| 97 | 25491492 |
CA |
2 | |
Radiotherapy, Sepsis, Infection, Clostridium difficile colitis, Colitis, Diverticulitis, Peripheral swelling, Joint swelling, Oral pain, Gingival pain, Ear pruritus, Pruritus, Diarrhoea, Abdominal pain lower, Mucosal inflammation, Rash, Oedema, Pain, Diarrhoea, Inappropriate schedule of product administration, Diverticulitis, Poor venous access, Poor venous access, Inappropriate schedule of product administration, Palmar-plantar erythrodysaesthesia syndrome, Inappropriate schedule of product administration, Diarrhoea, Inappropriate schedule of product administration, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, ROSUVASTATIN, PANTOPRAZOLE, CLOPIDOGREL, HYDROXYCHLOROQUINE, ALBUTEROL SULFATE, APIXABAN, |
||||
| 98 | 25491524 |
US |
63 | 2 |
Gastrointestinal scarring, Diarrhoea, Muscle spasms, Feeling abnormal, Weight increased, Weight decreased, Fatigue, Pain, Diarrhoea, Vomiting, Flatulence, Insomnia, General physical health deterioration, Intestinal obstruction, Abdominal pain, Nausea, Abdominal distension, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, PREDNISONE, |
||||
| 99 | 25491558 |
US |
75 | 2 |
Device breakage, Pain, Therapeutic product effect decreased, |
||||
ADALIMUMAB, |
||||
| 100 | 25491659 |
US |
||
Pain, |
||||
BACLOFEN INJECTION, BACLOFEN INJECTION, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-07-29